Muñoz-Novas, C., Poza-Santaella, M., González-Gascón y Marín, I., Hernández-Sánchez, M., Rodríguez-Vicente, A., Infante, M., . . . Hernández, J. (2018). The International Prognostic Index for Patients with Chronic Lymphocytic Leukemia Has the Higher Value in Predicting Overall Outcome Compared with the Barcelona-Brno Biomarkers Only Prognostic Model and the MD Anderson Cancer Center Prognostic Index. Biomed Res Int.
Chicago Style CitationMuñoz-Novas, Carolina, et al. "The International Prognostic Index for Patients With Chronic Lymphocytic Leukemia Has the Higher Value in Predicting Overall Outcome Compared With the Barcelona-Brno Biomarkers Only Prognostic Model and the MD Anderson Cancer Center Prognostic Index." Biomed Res Int 2018.
Cita MLAMuñoz-Novas, Carolina, et al. "The International Prognostic Index for Patients With Chronic Lymphocytic Leukemia Has the Higher Value in Predicting Overall Outcome Compared With the Barcelona-Brno Biomarkers Only Prognostic Model and the MD Anderson Cancer Center Prognostic Index." Biomed Res Int 2018.